{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T18:09:06Z","timestamp":1788890946063,"version":"build-2803163510"},"reference-count":196,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,11]],"date-time":"2025-04-11T00:00:00Z","timestamp":1744329600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","award":["RS-2023-00219517"],"award-info":[{"award-number":["RS-2023-00219517"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","award":["2020R1A2C2005620"],"award-info":[{"award-number":["2020R1A2C2005620"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","award":["2020M3A9G3080282"],"award-info":[{"award-number":["2020M3A9G3080282"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","award":["RS-2021-NR058546"],"award-info":[{"award-number":["RS-2021-NR058546"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","award":["2020R1A5A2031185"],"award-info":[{"award-number":["2020R1A5A2031185"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Liver Research"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.livres.2025.04.002","type":"journal-article","created":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T02:47:09Z","timestamp":1744426029000},"page":"104-117","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Nanoparticle-based therapeutic strategies for chronic liver diseases: Advances and insights"],"prefix":"10.1016","volume":"9","author":[{"given":"Sathiyamoorthy","family":"Padmanaban","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Won","family":"Baek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sai Sahithya","family":"Chamarthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saipriya","family":"Chandrasekaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antony V","family":"Samrot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijayakumar","family":"Gosu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8522-8236","authenticated-orcid":false,"given":"In-Kyu","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamalakannan","family":"Radhakrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Don-Kyu","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.livres.2025.04.002_bib1","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jhep.2022.09.001","article-title":"Loss of liver function in chronic liver disease: an identity crisis","volume":"78","author":"Berasain","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.livres.2025.04.002_bib2","doi-asserted-by":"crossref","first-page":"R1147","DOI":"10.1016\/j.cub.2017.09.019","article-title":"The liver","volume":"27","author":"Trefts","year":"2017","journal-title":"Curr Biol"},{"key":"10.1016\/j.livres.2025.04.002_bib3","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.3390\/jpm12101657","article-title":"Liver function-how to screen and to diagnose: insights from personal experiences, controlled clinical studies and future perspectives","volume":"12","author":"Buechter","year":"2022","journal-title":"J Pers Med"},{"key":"10.1016\/j.livres.2025.04.002_bib4","series-title":"Chronic Liver Disease. Geriatric Diseases: Evaluation and Management","first-page":"203","author":"Nagaratnam","year":"2018"},{"key":"10.1016\/j.livres.2025.04.002_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241310633","article-title":"Chronic liver disease: latest research in pathogenesis, detection and treatment","volume":"24","author":"De Siervi","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.livres.2025.04.002_bib6","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/s41575-023-00759-2","article-title":"Global epidemiology of cirrhosis \u2014 aetiology, trends and predictions","volume":"20","author":"Huang","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.livres.2025.04.002_bib7","doi-asserted-by":"crossref","first-page":"4166","DOI":"10.3748\/wjg.v29.i26.4166","article-title":"Mortality from chronic liver disease: recent trends and impact of the COVID-19 pandemic","volume":"29","author":"Fedeli","year":"2023","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.livres.2025.04.002_bib8","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jhep.2018.09.014","article-title":"Burden of liver diseases in the world","volume":"70","author":"Asrani","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.livres.2025.04.002_bib9","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/S0140-6736(21)01374-X","article-title":"Liver cirrhosis","volume":"398","author":"Gin\u00e8s","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.livres.2025.04.002_bib10","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1186\/s12889-024-17948-6","article-title":"Global burden of liver cirrhosis and other chronic liver diseases caused by specific etiologies from 1990 to 2019","volume":"24","author":"Wu","year":"2024","journal-title":"BMC Public Health"},{"key":"10.1016\/j.livres.2025.04.002_bib11","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1021\/acs.nanolett.3c03689","article-title":"Senescence of hepatic stellate cells by specific delivery of manganese for limiting liver fibrosis","volume":"24","author":"Gu","year":"2024","journal-title":"Nano Lett"},{"key":"10.1016\/j.livres.2025.04.002_bib12","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1086\/589722","article-title":"Excellent response rate to a double dose of the combined hepatitis A and B vaccine in previous nonresponders to hepatitis B vaccine","volume":"198","author":"Cardell","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.livres.2025.04.002_bib13","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1002\/hep.1840360704","article-title":"Course and outcome of hepatitis C","volume":"36","author":"Hoofnagle","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2025.04.002_bib14","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.jhep.2023.04.036","article-title":"Changing epidemiology, global trends and implications for outcomes of NAFLD","volume":"79","author":"Wong","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.livres.2025.04.002_bib15","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2025.04.002_bib16","doi-asserted-by":"crossref","first-page":"468","DOI":"10.3390\/biomedicines11020468","article-title":"Non-alcoholic fatty liver disease (NAFLD), type 2 diabetes, and non-viral hepatocarcinoma: pathophysiological mechanisms and new therapeutic strategies","volume":"11","author":"Vetrano","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.livres.2025.04.002_bib17","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1097\/MEG.0000000000002594","article-title":"Autoimmune liver diseases and diabetes","volume":"35","author":"Jensen","year":"2023","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.livres.2025.04.002_bib18","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s13578-023-01035-1","article-title":"Bile acid-mediated signaling in cholestatic liver diseases","volume":"13","author":"Zeng","year":"2023","journal-title":"Cell Biosci"},{"key":"10.1016\/j.livres.2025.04.002_bib19","doi-asserted-by":"crossref","first-page":"189","DOI":"10.4132\/jptm.2023.05.24","article-title":"A review of liver fibrosis and cirrhosis regression","volume":"57","author":"Lee","year":"2023","journal-title":"J Pathol Transl Med"},{"key":"10.1016\/j.livres.2025.04.002_bib20","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.livres.2023.05.004","article-title":"Progress on clinical prognosis assessment in liver failure","volume":"7","author":"Cai","year":"2023","journal-title":"Liver Res"},{"key":"10.1016\/j.livres.2025.04.002_bib21","doi-asserted-by":"crossref","first-page":"748","DOI":"10.3390\/antiox12030748","article-title":"Involvement of intracellular TAGE and the TAGE\u2013RAGE\u2013ROS axis in the onset and progression of NAFLD\/NASH","volume":"12","author":"Sakasai-Sakai","year":"2023","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.livres.2025.04.002_bib22","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1016\/j.ajpath.2023.06.002","article-title":"Oxidative stress-induced liver damage and remodeling of the liver vasculature","volume":"193","author":"Banerjee","year":"2023","journal-title":"Am J Pathol"},{"key":"10.1016\/j.livres.2025.04.002_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2023.122028","article-title":"Remodeling liver microenvironment by L-arginine loaded hollow polydopamine nanoparticles for liver cirrhosis treatment","volume":"295","author":"Wang","year":"2023","journal-title":"Biomaterials"},{"key":"10.1016\/j.livres.2025.04.002_bib24","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1039\/D2NH00289B","article-title":"Advances in nanoparticle-based mRNA delivery for liver cancer and liver-associated infectious diseases","volume":"8","author":"Chung","year":"2022","journal-title":"Nanoscale Horiz"},{"key":"10.1016\/j.livres.2025.04.002_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124381","article-title":"Targeting chronic liver diseases: molecular markers, drug delivery strategies and future perspectives","volume":"660","author":"Unagolla","year":"2024","journal-title":"Int J Pharm"},{"key":"10.1016\/j.livres.2025.04.002_bib26","doi-asserted-by":"crossref","first-page":"14","DOI":"10.33696\/Gastroenterology.4.044","article-title":"Preclinical promise and clinical challenges for innovative therapies targeting liver fibrogenesis","volume":"4","author":"Addissouky","year":"2023","journal-title":"Arch Gastroenterol Res"},{"key":"10.1016\/j.livres.2025.04.002_bib27","article-title":"Restoration of sinusoid fenestrae followed by targeted nanoassembly delivery of an anti-fibrotic agent improves treatment efficacy in liver fibrosis","volume":"35","author":"Li","year":"2023","journal-title":"Adv Mater"},{"key":"10.1016\/j.livres.2025.04.002_bib28","doi-asserted-by":"crossref","first-page":"87","DOI":"10.4331\/wjbc.v12.i5.87","article-title":"Alcoholic liver disease: current insights into cellular mechanisms","volume":"12","author":"Petagine","year":"2021","journal-title":"World J Biol Chem"},{"key":"10.1016\/j.livres.2025.04.002_bib29","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3390\/biomedicines6040106","article-title":"Alcoholic liver disease: alcohol metabolism, cascade of molecular mechanisms, cellular targets, and clinical aspects","volume":"6","author":"Teschke","year":"2018","journal-title":"Biomedicines"},{"key":"10.1016\/j.livres.2025.04.002_bib30","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.cld.2012.08.002","article-title":"Alcohol metabolism","volume":"16","author":"Cederbaum","year":"2012","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.livres.2025.04.002_bib31","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41572-018-0014-7","article-title":"Alcoholic liver disease","volume":"4","author":"Seitz","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.livres.2025.04.002_bib32","doi-asserted-by":"crossref","first-page":"178","DOI":"10.4161\/oxim.3.3.12288","article-title":"Acetaldehyde adducts in alcoholic liver disease","volume":"3","author":"Setshedi","year":"2010","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.livres.2025.04.002_bib33","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.toxrep.2023.10.005","article-title":"Alcohol-induced liver injury in signalling pathways and curcumin\u2019s therapeutic potential","volume":"11","author":"Subramaniyan","year":"2023","journal-title":"Toxicol Rep"},{"key":"10.1016\/j.livres.2025.04.002_bib34","first-page":"6321","article-title":"Reactive oxygen species (ROS)-mediated oxidative stress in chronic liver diseases and its mitigation by medicinal plants","volume":"15","author":"Sharma","year":"2023","journal-title":"Am J Transl Res"},{"key":"10.1016\/j.livres.2025.04.002_bib35","article-title":"HIGD1A links SIRT1 activity to adipose browning by inhibiting the ROS\/DNA damage pathway","volume":"42","author":"Li","year":"2023","journal-title":"Cell Rep"},{"key":"10.1016\/j.livres.2025.04.002_bib36","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/s41579-023-00904-3","article-title":"The gut\u2013liver axis and gut microbiota in health and liver disease","volume":"21","author":"Hsu","year":"2023","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.livres.2025.04.002_bib37","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1097\/HEP.0000000000000924","article-title":"Gut-liver axis: recent concepts in pathophysiology in alcohol-associated liver disease","volume":"80","author":"Raya Tonetti","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2025.04.002_bib38","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.livres.2023.01.001","article-title":"Novel insights into the impact of liver inflammatory responses on primary liver cancer development","volume":"7","author":"Ait-Ahmed","year":"2023","journal-title":"Liver Res"},{"key":"10.1016\/j.livres.2025.04.002_bib39","article-title":"Artemisitene alters LPS-induced oxidative stress, inflammation and ferroptosis in liver through Nrf2\/HO-1 and NF-kB pathway","volume":"14","author":"Zhao","year":"2023","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.livres.2025.04.002_bib40","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1016\/S0140-6736(14)60220-8","article-title":"Hepatitis B virus infection","volume":"384","author":"Tr\u00e9po","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.livres.2025.04.002_bib41","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1016\/j.jhep.2014.07.012","article-title":"Natural history of hepatitis C","volume":"61","author":"Westbrook","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.livres.2025.04.002_bib42","first-page":"5203","article-title":"Flow cytometric detection of hepatitis C virus antigens in infected peripheral blood leukocytes: binding and entry","volume":"11","author":"El-Awady","year":"2005","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.livres.2025.04.002_bib43","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1099\/vir.0.81169-0","article-title":"Analysis of the binding of hepatitis C virus genotype 1a and 1b E2 glycoproteins to peripheral blood mononuclear cell subsets","volume":"86","author":"Yamada","year":"2005","journal-title":"J Gen Virol"},{"key":"10.1016\/j.livres.2025.04.002_bib44","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.jhep.2022.12.013","article-title":"Activation of CD4 T cells during prime immunization determines the success of a therapeutic hepatitis B vaccine in HBV-carrier mouse models","volume":"78","author":"Su","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.livres.2025.04.002_bib45","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.1038\/s41467-023-39148-3","article-title":"Targeted viral adaptation generates a simian-tropic hepatitis B virus that infects marmoset cells","volume":"14","author":"Liu","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.livres.2025.04.002_bib46","article-title":"A human monoclonal antibody against HBsAg for the prevention and treatment of chronic HBV and HDV infection","volume":"5","author":"Burm","year":"2022","journal-title":"JHEP Rep"},{"key":"10.1016\/j.livres.2025.04.002_bib47","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1093\/infdis\/jiad340","article-title":"Alternating arenavirus vector immunization generates robust polyfunctional genotype cross-reactive hepatitis B virus\u2013specific CD8 T-cell responses and high anti\u2013hepatitis B surface antigen titers","volume":"229","author":"Schmidt","year":"2024","journal-title":"J Infect Dis"},{"key":"10.1016\/j.livres.2025.04.002_bib48","first-page":"177","article-title":"Progression from acute to chronic hepatitis B is more common in older adults","volume":"87","author":"McKeating","year":"2018","journal-title":"Ulster Med J"},{"key":"10.1016\/j.livres.2025.04.002_bib49","doi-asserted-by":"crossref","first-page":"7896","DOI":"10.3748\/wjg.v19.i44.7896","article-title":"An insight into the diagnosis and pathogenesis of hepatitis C virus infection","volume":"19","author":"Irshad","year":"2013","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.livres.2025.04.002_bib50","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.jhep.2023.12.016","article-title":"Efficient formation and maintenance of humoral and CD4 T-cell immunity targeting the viral capsid in acute-resolving hepatitis E infection","volume":"80","author":"Csernalabics","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.livres.2025.04.002_bib51","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/978-981-99-1304-6_7","article-title":"Immunobiology and host response to HEV","volume":"1417","author":"Zhou","year":"2023","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.livres.2025.04.002_bib52","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.00846-24","article-title":"Optimization of immunosuppression strategies for the establishment of chronic hepatitis E virus infection in rabbits","volume":"98","author":"He","year":"2024","journal-title":"J Virol"},{"key":"10.1016\/j.livres.2025.04.002_bib53","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.livres.2025.04.002_bib54","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/nrgastro.2016.147","article-title":"NAFLD and diabetes mellitus","volume":"14","author":"Tilg","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.livres.2025.04.002_bib55","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/hep.29466","article-title":"Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease","volume":"67","author":"Estes","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2025.04.002_bib56","first-page":"661","article-title":"Noninvasive diagnosis of NASH and liver fibrosis within the spectrum of NAFLD","volume":"8","author":"Alkhouri","year":"2012","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"10.1016\/j.livres.2025.04.002_bib57","doi-asserted-by":"crossref","first-page":"G1310","DOI":"10.1152\/ajpgi.00365.2011","article-title":"Hepatic recruitment of macrophages promotes nonalcoholic steatohepatitis through CCR2","volume":"302","author":"Miura","year":"2012","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.livres.2025.04.002_bib58","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1055\/s-0040-1708876","article-title":"Hepatic Stellate cell-macrophage crosstalk in liver fibrosis and carcinogenesis","volume":"40","author":"Matsuda","year":"2020","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.livres.2025.04.002_bib59","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1113\/jphysiol.2011.219691","article-title":"Role of innate immunity and the microbiota in liver fibrosis: crosstalk between the liver and gut","volume":"590","author":"Seki","year":"2012","journal-title":"J Physiol"},{"issue":"Suppl 2","key":"10.1016\/j.livres.2025.04.002_bib60","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s12072-013-9468-6","article-title":"Immune and inflammatory pathways in NASH","volume":"7","author":"Ganz","year":"2013","journal-title":"Hepatol Int"},{"key":"10.1016\/j.livres.2025.04.002_bib61","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/nm1663","article-title":"TLR4 enhances TGF-beta signaling and hepatic fibrosis","volume":"13","author":"Seki","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.livres.2025.04.002_bib62","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.cellimm.2017.10.006","article-title":"Non-alcoholic steatohepatitis induces transient changes within the liver macrophage pool","volume":"322","author":"Devisscher","year":"2017","journal-title":"Cell Immunol"},{"key":"10.1016\/j.livres.2025.04.002_bib63","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.jhep.2019.03.016","article-title":"Unveiling the depletion of Kupffer cells in experimental hepatocarcinogenesis through liver macrophage subtype-specific markers","volume":"71","author":"Lefere","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.livres.2025.04.002_bib64","doi-asserted-by":"crossref","first-page":"774","DOI":"10.3390\/ijms17050774","article-title":"The natural course of non-alcoholic fatty liver disease","volume":"17","author":"Calzadilla Bertot","year":"2016","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.livres.2025.04.002_bib65","doi-asserted-by":"crossref","first-page":"7832","DOI":"10.1021\/acs.jafc.3c08108","article-title":"Lycopene alleviates endoplasmic reticulum stress in steatohepatitis through inhibition of the ASK1\u2013JNK signaling pathway","volume":"72","author":"Song","year":"2024","journal-title":"J Agric Food Chem"},{"key":"10.1016\/j.livres.2025.04.002_bib66","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/j.lfs.2006.06.024","article-title":"Past and future approaches to ischemia-reperfusion lesion associated with liver transplantation","volume":"79","author":"Casillas-Ram\u00edrez","year":"2006","journal-title":"Life Sci"},{"key":"10.1016\/j.livres.2025.04.002_bib67","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1016\/j.transproceed.2007.09.044","article-title":"Ischemic preconditioning and intermittent clamping increase the tolerance of fatty liver to hepatic ischemia-reperfusion injury in the rat","volume":"39","author":"Saidi","year":"2007","journal-title":"Transplant Proc"},{"key":"10.1016\/j.livres.2025.04.002_bib68","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1097\/00007890-199205000-00001","article-title":"Preservation and reperfusion injuries in liver allografts. An overview and synthesis of current studies","volume":"53","author":"Clavien","year":"1992","journal-title":"Transplantation"},{"key":"10.1016\/j.livres.2025.04.002_bib69","doi-asserted-by":"crossref","first-page":"6654","DOI":"10.1016\/S0021-9258(19)50477-X","article-title":"Effect of anoxia on intracellular ATP, Na+ i, Ca2+ i, Mg2+ i, and cytotoxicity in rat hepatocytes","volume":"267","author":"Gasbarrini","year":"1992","journal-title":"J Biol Chem"},{"key":"10.1016\/j.livres.2025.04.002_bib70","doi-asserted-by":"crossref","first-page":"G163","DOI":"10.1152\/ajpgi.2000.279.1.G163","article-title":"Hepatic preconditioning preserves energy metabolism during sustained ischemia","volume":"279","author":"Peralta","year":"2000","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.livres.2025.04.002_bib71","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1139\/cjpp-2017-0768","article-title":"Cellular crosstalk mediated by platelet-derived growth factor BB and transforming growth factor \u03b2 during hepatic injury activates hepatic stellate cells","volume":"96","author":"Mekala","year":"2018","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1016\/j.livres.2025.04.002_bib72","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1080\/17474124.2021.1949289","article-title":"Chronic liver disease and oxidative stress\u2013a narrative review","volume":"15","author":"Seen","year":"2021","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.livres.2025.04.002_bib73","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cbi.2005.12.009","article-title":"Free radicals, metals and antioxidants in oxidative stress-induced cancer","volume":"160","author":"Valko","year":"2006","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.livres.2025.04.002_bib74","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.3390\/ijms20102407","article-title":"Chemical basis of reactive oxygen species reactivity and involvement in neurodegenerative diseases","volume":"20","author":"Collin","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.livres.2025.04.002_bib75","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3390\/livers2040023","article-title":"Role of oxidative stress in liver disorders","volume":"2","author":"Conde de la Rosa","year":"2022","journal-title":"Livers"},{"key":"10.1016\/j.livres.2025.04.002_bib76","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.cotox.2017.10.003","article-title":"Role of cytochrome P450s in the generation and metabolism of reactive oxygen species","volume":"7","author":"Veith","year":"2018","journal-title":"Curr Opin Toxicol"},{"key":"10.1016\/j.livres.2025.04.002_bib77","first-page":"50","article-title":"Immune dysfunction in cirrhosis","volume":"5","author":"Noor","year":"2017","journal-title":"J Clin Transl Hepatol"},{"key":"10.1016\/j.livres.2025.04.002_bib78","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1053\/jhep.2003.50472","article-title":"Kupffer cell engulfment of apoptotic bodies stimulates death ligand and cytokine expression","volume":"38","author":"Canbay","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2025.04.002_bib79","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/S0140-6736(14)60121-5","article-title":"Liver cirrhosis","volume":"383","author":"Tsochatzis","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.livres.2025.04.002_bib80","doi-asserted-by":"crossref","first-page":"G667","DOI":"10.1152\/ajpgi.00050.2016","article-title":"Dysregulation of redox pathways in liver fibrosis","volume":"311","author":"Torok","year":"2016","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.livres.2025.04.002_bib81","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.molcel.2010.09.023","article-title":"Autophagy and the integrated stress response","volume":"40","author":"Kroemer","year":"2010","journal-title":"Mol Cell"},{"key":"10.1016\/j.livres.2025.04.002_bib82","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1042\/bse0550105","article-title":"Autophagy and cell death","volume":"55","author":"Yonekawa","year":"2013","journal-title":"Essays Biochem"},{"key":"10.1016\/j.livres.2025.04.002_bib83","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/nrgastro.2016.185","article-title":"Autophagy in the liver: functions in health and disease","volume":"14","author":"Ueno","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.livres.2025.04.002_bib84","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1128\/MCB.25.3.1025-1040.2005","article-title":"Inhibition of macroautophagy triggers apoptosis","volume":"25","author":"Boya","year":"2005","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.livres.2025.04.002_bib85","doi-asserted-by":"crossref","first-page":"3448","DOI":"10.1016\/j.bbamcr.2013.06.001","article-title":"Crosstalk between apoptosis, necrosis and autophagy","volume":"1833","author":"Nikoletopoulou","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.livres.2025.04.002_bib86","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1080\/15384101.2015.1038685","article-title":"Autophagy and apoptosis in liver injury","volume":"14","author":"Wang","year":"2015","journal-title":"Cell Cycle"},{"key":"10.1016\/j.livres.2025.04.002_bib87","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1053\/j.gastro.2016.02.035","article-title":"Linking pathogenic mechanisms of alcoholic liver disease with clinical phenotypes","volume":"150","author":"Nagy","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.livres.2025.04.002_bib88","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1053\/j.gastro.2010.07.041","article-title":"Autophagy reduces acute ethanol-induced hepatotoxicity and steatosis in mice","volume":"139","author":"Ding","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.livres.2025.04.002_bib89","first-page":"1143","article-title":"Ethanol-induced mitophagy in liver is associated with activation of the PINK1-Parkin pathway triggered by oxidative DNA damage","volume":"31","author":"Eid","year":"2016","journal-title":"Histol Histopathol"},{"key":"10.1016\/j.livres.2025.04.002_bib90","doi-asserted-by":"crossref","first-page":"G324","DOI":"10.1152\/ajpgi.00108.2015","article-title":"Parkin regulates mitophagy and mitochondrial function to protect against alcohol-induced liver injury and steatosis in mice","volume":"309","author":"Williams","year":"2015","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.livres.2025.04.002_bib91","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.jhep.2013.01.011","article-title":"Pharmacological promotion of autophagy alleviates steatosis and injury in alcoholic and non-alcoholic fatty liver conditions in mice","volume":"58","author":"Lin","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.livres.2025.04.002_bib92","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/hep.510260419","article-title":"Flow cytometric analysis of vesicular pH in rat hepatocytes after ethanol administration","volume":"26","author":"Kharbanda","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2025.04.002_bib93","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0304-4165(96)00043-8","article-title":"Ethanol consumption alters trafficking of lysosomal enzymes and affects the processing of procathepsin L in rat liver","volume":"1291","author":"Kharbanda","year":"1996","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.livres.2025.04.002_bib94","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1111\/acer.12904","article-title":"Acute and chronic ethanol administration differentially modulate hepatic autophagy and transcription factor EB","volume":"39","author":"Thomes","year":"2015","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.livres.2025.04.002_bib95","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1053\/j.gastro.2018.05.027","article-title":"Impaired TFEB-mediated lysosome biogenesis and autophagy promote chronic ethanol-induced liver injury and steatosis in mice","volume":"155","author":"Chao","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.livres.2025.04.002_bib96","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1111\/hepr.12282","article-title":"Abnormality of autophagic function and cathepsin expression in the liver from patients with non-alcoholic fatty liver disease","volume":"44","author":"Fukuo","year":"2014","journal-title":"Hepatol Res"},{"key":"10.1016\/j.livres.2025.04.002_bib97","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.cmet.2010.04.005","article-title":"Defective hepatic autophagy in obesity promotes ER stress and causes insulin resistance","volume":"11","author":"Yang","year":"2010","journal-title":"Cell Metab"},{"key":"10.1016\/j.livres.2025.04.002_bib98","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.33549\/physiolres.932394","article-title":"Effect of short- and long-term high-fat feeding on autophagy flux and lysosomal activity in rat liver","volume":"61","author":"Pap\u00e1\u010dkov\u00e1","year":"2012","journal-title":"Physiol Res"},{"key":"10.1016\/j.livres.2025.04.002_bib99","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1016\/j.ajpath.2016.03.003","article-title":"Lipid-induced endoplasmic reticulum stress impairs selective autophagy at the step of autophagosome-lysosome fusion in hepatocytes","volume":"186","author":"Miyagawa","year":"2016","journal-title":"Am J Pathol"},{"key":"10.1016\/j.livres.2025.04.002_bib100","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1002\/hep.28820","article-title":"Rubicon inhibits autophagy and accelerates hepatocyte apoptosis and lipid accumulation in nonalcoholic fatty liver disease in mice","volume":"64","author":"Tanaka","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2025.04.002_bib101","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/ncb2718","article-title":"TFEB controls cellular lipid metabolism through a starvation-induced autoregulatory loop","volume":"15","author":"Settembre","year":"2013","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.livres.2025.04.002_bib102","doi-asserted-by":"crossref","first-page":"4834","DOI":"10.1038\/ncomms5834","article-title":"Pharmacological correction of obesity-induced autophagy arrest using calcium channel blockers","volume":"5","author":"Park","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.livres.2025.04.002_bib103","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1002\/hep.26667","article-title":"Caffeine stimulates hepatic lipid metabolism by the autophagy-lysosomal pathway in mice","volume":"59","author":"Sinha","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2025.04.002_bib104","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1309\/AJCP53YVVJCNDZIR","article-title":"p62+ Hyaline inclusions in intrahepatic cholangiocarcinoma associated with viral hepatitis or alcoholic liver disease","volume":"134","author":"Aishima","year":"2010","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.livres.2025.04.002_bib105","article-title":"Role of autophagy in liver diseases","volume":"30","author":"Morishita","year":"2022","journal-title":"Curr Opin Physiol"},{"key":"10.1016\/j.livres.2025.04.002_bib106","doi-asserted-by":"crossref","first-page":"8081","DOI":"10.3748\/wjg.v27.i47.8081","article-title":"Present and future management of viral hepatitis","volume":"27","author":"Gonz\u00e1lez Grande","year":"2021","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.livres.2025.04.002_bib107","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1365-2036.2007.03390.x","article-title":"Low serum HBV DNA levels and development of hepatocellular carcinoma in patients with chronic hepatitis B: a case\u2013control study","volume":"26","author":"Fung","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.livres.2025.04.002_bib108","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1365-2893.2005.00603.x","article-title":"The relationship between HBV-DNA levels and cirrhosis-related complications in Chinese with chronic hepatitis B","volume":"12","author":"Yuan","year":"2005","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.livres.2025.04.002_bib109","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.28105","article-title":"A phase 2 open label study of ledipasvir\/sofosbuvir for 12 weeks in subjects with hepatitis B virus infection","volume":"95","author":"Price","year":"2023","journal-title":"J Med Virol"},{"key":"10.1016\/j.livres.2025.04.002_bib110","article-title":"Real-world effectiveness of voxilaprevir\/velpatasvir\/sofosbuvir in patients following DAA failure","volume":"6","author":"Graf","year":"2024","journal-title":"JHEP Rep"},{"key":"10.1016\/j.livres.2025.04.002_bib111","doi-asserted-by":"crossref","first-page":"4710","DOI":"10.1016\/S0264-410X(01)00240-7","article-title":"A prospective, randomized, comparative US trial of a combination hepatitis A and B vaccine (Twinrix) with corresponding monovalent vaccines (Havrix and Engerix-B) in adults","volume":"19","author":"Joines","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.livres.2025.04.002_bib112","first-page":"166","article-title":"Comparative pharmacokinetics and pharmacodynamics of two recombinant human interferon alpha-2b formulations administered intramuscularly in healthy male volunteers","volume":"17","author":"Rodr\u00edguez","year":"2000","journal-title":"Biotecnol Apl"},{"key":"10.1016\/j.livres.2025.04.002_bib113","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.jceh.2018.07.004","article-title":"New direct-acting antivirals for the treatment of patients with hepatitis C virus infection: a systematic review of randomized controlled trials","volume":"9","author":"Pecoraro","year":"2019","journal-title":"J Clin Exp Hepatol"},{"key":"10.1016\/j.livres.2025.04.002_bib114","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s40265-018-0864-z","article-title":"Ledipasvir\/sofosbuvir: a review in chronic hepatitis C","volume":"78","author":"Scott","year":"2018","journal-title":"Drugs"},{"key":"10.1016\/j.livres.2025.04.002_bib115","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S1473-3099(19)30417-7","article-title":"Serological response to three alternative series of hepatitis B revaccination (Fendrix, Twinrix, and HBVaxPro-40) in healthy non-responders: a multicentre, open-label, randomised, controlled, superiority trial","volume":"20","author":"Raven","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.livres.2025.04.002_bib116","doi-asserted-by":"crossref","first-page":"749","DOI":"10.5414\/CP203651","article-title":"A randomized, open-label, crossover study to compare the safety and pharmacokinetics of two tablet formulations of tenofovir (tenofovir disoproxil and tenofovir disoproxil fumarate) in healthy subjects","volume":"58","author":"Yun","year":"2020","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1016\/j.livres.2025.04.002_bib117","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2147\/DDDT.S379964","article-title":"Bulevirtide in the treatment of hepatitis delta: drug discovery, clinical development and place in therapy","volume":"17","author":"Soriano","year":"2023","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.livres.2025.04.002_bib118","article-title":"Long-term open-label vebicorvir for chronic HBV infection: safety and off-treatment responses","volume":"6","author":"Yuen","year":"2024","journal-title":"JHEP Rep"},{"key":"10.1016\/j.livres.2025.04.002_bib119","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1093\/jac\/dkab491","article-title":"Safety, antiviral activity and pharmacokinetics of JNJ-64530440, a novel capsid assembly modulator, as 4 week monotherapy in treatment-naive patients with chronic hepatitis B virus infection","volume":"77","author":"Gane","year":"2022","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.livres.2025.04.002_bib120","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S2468-1253(17)30288-1","article-title":"Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trial","volume":"2","author":"Bazinet","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.livres.2025.04.002_bib121","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.jhep.2022.09.027","article-title":"Safety and efficacy of the oral TLR8 agonist selgantolimod in individuals with chronic hepatitis B under viral suppression","volume":"78","author":"Gane","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.livres.2025.04.002_bib122","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1161\/CIRCULATIONAHA.116.022188","article-title":"Clinical trial of the protein farnesylation inhibitors lonafarnib, pravastatin, and zoledronic acid in children with Hutchinson-Gilford progeria syndrome","volume":"134","author":"Gordon","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.livres.2025.04.002_bib123","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2024.155912","article-title":"Deciphering the molecular pathways of saroglitazar: a dual PPAR \u03b1\/\u03b3 agonist for managing metabolic NAFLD","volume":"155","author":"Ezhilarasan","year":"2024","journal-title":"Metabolism"},{"key":"10.1016\/j.livres.2025.04.002_bib124","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0243911","article-title":"The pharmacodynamic and differential gene expression analysis of PPAR \u03b1\/\u03b4 agonist GFT505 in CDAHFD-induced NASH model","volume":"15","author":"Liu","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.livres.2025.04.002_bib125","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa2036205","article-title":"A randomized, controlled trial of the Pan-PPAR agonist lanifibranor in NASH","volume":"385","author":"Francque","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.livres.2025.04.002_bib126","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s10620-019-5477-1","article-title":"Empagliflozin for the treatment of nonalcoholic steatohepatitis in patients with type 2 diabetes mellitus","volume":"65","author":"Lai","year":"2020","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.livres.2025.04.002_bib127","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1080\/13543776.2023.2274905","article-title":"An updated patent review of GLP-1 receptor agonists (2020-present)","volume":"33","author":"Lu","year":"2023","journal-title":"Expert Opin Ther Pat"},{"key":"10.1016\/j.livres.2025.04.002_bib128","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11892-023-01530-2","article-title":"Polyagonists in type 2 diabetes management","volume":"24","author":"Dissanayake","year":"2024","journal-title":"Curr Diab Rep"},{"key":"10.1016\/j.livres.2025.04.002_bib129","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1053\/j.gastro.2021.07.025","article-title":"TVB-2640 (FASN inhibitor) for the treatment of nonalcoholic steatohepatitis: FASCINATE-1, a randomized, placebo-controlled phase 2a trial","volume":"161","author":"Loomba","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.livres.2025.04.002_bib130","doi-asserted-by":"crossref","first-page":"848","DOI":"10.3390\/biomedicines12040848","article-title":"Namodenoson at the crossroad of metabolic dysfunction-associated steatohepatitis and hepatocellular carcinoma","volume":"12","author":"Etzion","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.livres.2025.04.002_bib131","doi-asserted-by":"crossref","first-page":"2","DOI":"10.21037\/tgh.2019.09.06","article-title":"Genetic and epigenetic disease modifiers: non-alcoholic fatty liver disease (NAFLD) and alcoholic liver disease (ALD)","volume":"6","author":"Choudhary","year":"2021","journal-title":"Transl Gastroenterol Hepatol"},{"key":"10.1016\/j.livres.2025.04.002_bib132","doi-asserted-by":"crossref","first-page":"107","DOI":"10.14309\/ajg.0000000000002275","article-title":"Safety, pharmacokinetics, and efficacy signals of larsucosterol (DUR-928) in alcohol-associated hepatitis","volume":"119","author":"Hassanein","year":"2024","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.livres.2025.04.002_bib133","article-title":"The role of gut microbiota, exosomes, and their interaction in the pathogenesis of ALD","author":"Cheng","year":"202572353","journal-title":"J Adv Res"},{"key":"10.1016\/j.livres.2025.04.002_bib134","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1080\/10715762.2018.1459042","article-title":"Alda-1, an ALDH2 activator, protects against hepatic ischemia\/reperfusion injury in rats via inhibition of oxidative stress","volume":"52","author":"Zhang","year":"2018","journal-title":"Free Radic Res"},{"key":"10.1016\/j.livres.2025.04.002_bib135","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/3236911","article-title":"Discussion on the mechanism of Gandoufumu Decoction attenuates liver damage of Wilson\u2019s disease by inhibiting autophagy through the PI3K\/Akt\/mTOR pathway based on network pharmacology and experimental verification","volume":"2023","author":"Tang","year":"2023","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.livres.2025.04.002_bib136","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1159\/000505189","article-title":"A new era in systemic therapy for hepatocellular carcinoma: atezolizumab plus bevacizumab combination therapy","volume":"9","author":"Kudo","year":"2020","journal-title":"Liver Cancer"},{"key":"10.1016\/j.livres.2025.04.002_bib137","doi-asserted-by":"crossref","first-page":"592","DOI":"10.21037\/hbsn-22-143","article-title":"Durvalumab plus tremelimumab in unresectable hepatocellular carcinoma","volume":"11","author":"Kudo","year":"2022","journal-title":"Hepatobiliary Surg Nutr"},{"key":"10.1016\/j.livres.2025.04.002_bib138","doi-asserted-by":"crossref","first-page":"993","DOI":"10.3949\/ccjm.73.11.993","article-title":"Risks and benefits of bariatric surgery: current evidence","volume":"73","author":"Brethauer","year":"2006","journal-title":"Cleve Clin J Med"},{"key":"10.1016\/j.livres.2025.04.002_bib139","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40265-012-0004-0","article-title":"Nonalcoholic fatty liver disease: current issues and novel treatment approaches","volume":"73","author":"Lomonaco","year":"2013","journal-title":"Drugs"},{"key":"10.1016\/j.livres.2025.04.002_bib140","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/jama.2021.7683","article-title":"Diagnosis and treatment of alcohol-associated liver disease: a review","volume":"326","author":"Singal","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.livres.2025.04.002_bib141","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/hep.30866","article-title":"Diagnosis and treatment of alcohol-associated liver diseases: 2019 practice guidance from the American Association for the Study of Liver Diseases","volume":"71","author":"Crabb","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2025.04.002_bib142","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.semcancer.2010.10.007","article-title":"The tumor microenvironment in hepatocellular carcinoma: current status and therapeutic targets","volume":"21","author":"Yang","year":"2011","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.livres.2025.04.002_bib143","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S1535-6108(04)00058-3","article-title":"Focus on hepatocellular carcinoma","volume":"5","author":"Bruix","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1016\/j.livres.2025.04.002_bib144","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1749-6632.2009.03704.x","article-title":"Inflammation and liver cancer: new molecular links","volume":"1155","author":"Berasain","year":"2009","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.livres.2025.04.002_bib145","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/187204","article-title":"The inflammatory microenvironment in hepatocellular carcinoma: a pivotal role for tumor-associated macrophages","volume":"2013","author":"Capece","year":"2013","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.livres.2025.04.002_bib146","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1189\/jlb.0609385","article-title":"Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation","volume":"86","author":"Solinas","year":"2009","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.livres.2025.04.002_bib147","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.imbio.2009.06.014","article-title":"Cellular and molecular pathways linking inflammation and cancer","volume":"214","author":"Porta","year":"2009","journal-title":"Immunobiology"},{"key":"10.1016\/j.livres.2025.04.002_bib148","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1002\/ptr.6171","article-title":"Milk thistle (Silybum marianum): a concise overview on its chemistry, pharmacological, and nutraceutical uses in liver diseases","volume":"32","author":"Abenavoli","year":"2018","journal-title":"Phytother Res"},{"key":"10.1016\/j.livres.2025.04.002_bib149","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2022.116043","article-title":"The role of Iron in lipid peroxidation and protein nitration during acetaminophen-induced liver injury in mice","volume":"445","author":"Adelusi","year":"2022","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.livres.2025.04.002_bib150","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1080\/13813455.2018.1437186","article-title":"Protective and anti-inflammatory effects of hydroalcoholic leaf extract of Origanum vulgare on oxidative stress, TNF-\u03b1 gene expression and liver histological changes in paraquat-induced hepatotoxicity in rats","volume":"125","author":"Sharifi-Rigi","year":"2019","journal-title":"Arch Physiol Biochem"},{"key":"10.1016\/j.livres.2025.04.002_bib151","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0191353","article-title":"Silymarin prevents acetaminophen-induced hepatotoxicity in mice","volume":"13","author":"Papackova","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.livres.2025.04.002_bib152","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.intimp.2017.03.027","article-title":"Multi-targeted protection of acetaminophen-induced hepatotoxicity in mice by tannic acid","volume":"47","author":"Zhang","year":"2017","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.livres.2025.04.002_bib153","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.metabol.2017.09.002","article-title":"Immunomodulatory liposomes targeting liver macrophages arrest progression of nonalcoholic steatohepatitis","volume":"78","author":"Maradana","year":"2018","journal-title":"Metabolism"},{"key":"10.1016\/j.livres.2025.04.002_bib154","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1021\/acsptsci.3c00210","article-title":"Liposome-based silibinin for mitigating nonalcoholic fatty liver disease: dual effects via parenteral and intestinal routes","volume":"6","author":"Yan","year":"2023","journal-title":"ACS Pharmacol Transl Sci"},{"key":"10.1016\/j.livres.2025.04.002_bib155","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.2217\/nnm-2017-0119","article-title":"Nanoliposome improves inhibitory effects of naringenin on nonalcoholic fatty liver disease in mice","volume":"12","author":"Chen","year":"2017","journal-title":"Nanomedicine (Lond)"},{"key":"10.1016\/j.livres.2025.04.002_bib156","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106208","article-title":"Baicalin and its nanoliposomes ameliorates nonalcoholic fatty liver disease via suppression of TLR4 signaling cascade in mice","volume":"80","author":"Liu","year":"2020","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.livres.2025.04.002_bib157","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.foodchem.2012.02.101","article-title":"Anti-obesity effect of Schisandra chinensis in 3T3-L1 cells and high fat diet-induced obese rats","volume":"134","author":"Park","year":"2012","journal-title":"Food Chem"},{"key":"10.1016\/j.livres.2025.04.002_bib158","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jep.2016.03.021","article-title":"Schisandra chinensis extract ameliorates nonalcoholic fatty liver via inhibition of endoplasmic reticulum stress","volume":"185","author":"Jang","year":"2016","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.livres.2025.04.002_bib159","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jconrel.2024.02.022","article-title":"Engineered liposomes targeting hepatic stellate cells overcome pathological barriers and reverse liver fibrosis","volume":"368","author":"Wang","year":"2024","journal-title":"J Control Release"},{"key":"10.1016\/j.livres.2025.04.002_bib160","doi-asserted-by":"crossref","first-page":"3943","DOI":"10.2147\/IJN.S202821","article-title":"Mixed micelles loaded with the 5-benzylidenethiazolidine-2,4-dione derivative SKLB023 for efficient treatment of non-alcoholic steatohepatitis","volume":"14","author":"Li","year":"2019","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.livres.2025.04.002_bib161","doi-asserted-by":"crossref","first-page":"4877","DOI":"10.1021\/acsabm.3c00612","article-title":"Targeted delivery of celastrol via chondroitin sulfate derived hybrid micelles for alleviating symptoms in nonalcoholic fatty liver disease","volume":"6","author":"Pan","year":"2023","journal-title":"ACS Appl Bio Mater"},{"key":"10.1016\/j.livres.2025.04.002_bib162","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2023.122047","article-title":"Self-assembling polymer-based short chain fatty acid prodrugs ameliorate non-alcoholic steatohepatitis and liver fibrosis","volume":"295","author":"Shashni","year":"2023","journal-title":"Biomaterials"},{"key":"10.1016\/j.livres.2025.04.002_bib163","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3389\/fchem.2020.00407","article-title":"Rapamycin-loaded mPEG-PLGA nanoparticles ameliorate hepatic steatosis and liver injury in non-alcoholic fatty liver disease","volume":"8","author":"Zhao","year":"2020","journal-title":"Front Chem"},{"key":"10.1016\/j.livres.2025.04.002_bib164","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.3390\/app11073044","article-title":"Effect of selenium nanoparticles on carbon tetrachloride-induced hepatotoxicity in the Swiss albino rats","volume":"11","author":"Ebaid","year":"2021","journal-title":"Appl Sci"},{"key":"10.1016\/j.livres.2025.04.002_bib165","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.jhep.2015.10.020","article-title":"Cerium oxide nanoparticles reduce steatosis, portal hypertension and display anti-inflammatory properties in rats with liver fibrosis","volume":"64","author":"Or\u00f3","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.livres.2025.04.002_bib166","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jcis.2023.10.019","article-title":"Mn3O4 nanozymes prevent acetaminophen-induced acute liver injury by attenuating oxidative stress and countering inflammation","volume":"654","author":"Liu","year":"2024","journal-title":"J Colloid Interface Sci"},{"key":"10.1016\/j.livres.2025.04.002_bib167","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0018033","article-title":"Enhancement of naringenin bioavailability by complexation with hydroxypropyl-\u03b2-cyclodextrin","volume":"6","author":"Shulman","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.livres.2025.04.002_bib168","doi-asserted-by":"crossref","first-page":"196","DOI":"10.2174\/1389201019666180514170122","article-title":"Naringenin and its nano-formulations for fatty liver: cellular modes of action and clinical perspective","volume":"19","author":"Zobeiri","year":"2018","journal-title":"Curr Pharm Biotechnol"},{"key":"10.1016\/j.livres.2025.04.002_bib169","doi-asserted-by":"crossref","first-page":"23405","DOI":"10.1021\/acsnano.3c04636","article-title":"BMI1 silencing liposomes suppress postradiotherapy cancer stemness against radioresistant hepatocellular carcinoma","volume":"17","author":"Zhu","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.livres.2025.04.002_bib170","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.actbio.2022.04.021","article-title":"Preclinical validation of silibinin\/albumin nanoparticles as an applicable system against acute liver injury","volume":"146","author":"Ding","year":"2022","journal-title":"Acta Biomater"},{"key":"10.1016\/j.livres.2025.04.002_bib171","doi-asserted-by":"crossref","DOI":"10.1002\/mnfr.201701057","article-title":"The oral bioavailability of trans-resveratrol from a grapevine-shoot extract in healthy humans is significantly increased by micellar solubilization","volume":"62","author":"Calvo-Castro","year":"2018","journal-title":"Mol Nutr Food Res"},{"key":"10.1016\/j.livres.2025.04.002_bib172","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.colsurfb.2009.03.029","article-title":"Solubilization of resveratrol in micellar solutions of different bile acids","volume":"72","author":"Atanackovi\u0107","year":"2009","journal-title":"Colloids Surf B Biointerfaces"},{"key":"10.1016\/j.livres.2025.04.002_bib173","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.3390\/ijms20061381","article-title":"Progress to improve oral bioavailability and beneficial effects of resveratrol","volume":"20","author":"Chimento","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.livres.2025.04.002_bib174","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1111\/nure.12081","article-title":"Effects of resveratrol supplementation on plasma lipids: a systematic review and meta-analysis of randomized controlled trials","volume":"71","author":"Sahebkar","year":"2013","journal-title":"Nutr Rev"},{"key":"10.1016\/j.livres.2025.04.002_bib175","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ijcard.2015.04.008","article-title":"Lack of efficacy of resveratrol on C-reactive protein and selected cardiovascular risk factors--results from a systematic review and meta-analysis of randomized controlled trials","volume":"189","author":"Sahebkar","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.livres.2025.04.002_bib176","doi-asserted-by":"crossref","first-page":"933","DOI":"10.3390\/nu13030933","article-title":"The role of resveratrol in liver disease: a comprehensive review from in vitro to clinical trials","volume":"13","author":"Izzo","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.livres.2025.04.002_bib177","doi-asserted-by":"crossref","first-page":"164","DOI":"10.3892\/etm.2015.2895","article-title":"Bioavailability and safety study of resveratrol 500 mg tablets in healthy male and female volunteers","volume":"11","author":"Sergides","year":"2016","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.livres.2025.04.002_bib178","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s00280-010-1525-4","article-title":"Pharmacokinetics, oral bioavailability, and metabolic profile of resveratrol and its dimethylether analog, pterostilbene, in rats","volume":"68","author":"Kapetanovic","year":"2011","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.livres.2025.04.002_bib179","article-title":"Multicompartment polyion complex micelles based on triblock polypept(o)ides mediate efficient siRNA delivery to cancer-associated fibroblasts for antistromal therapy of hepatocellular carcinoma","volume":"36","author":"Schneider","year":"2024","journal-title":"Adv Mater"},{"key":"10.1016\/j.livres.2025.04.002_bib180","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.3390\/antiox12071405","article-title":"Rising influence of nanotechnology in addressing oxidative stress-related liver disorders","volume":"12","author":"Padmanaban","year":"2023","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.livres.2025.04.002_bib181","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2019.119467","article-title":"Manganese dioxide nanoparticles protect cartilage from inflammation-induced oxidative stress","volume":"224","author":"Kumar","year":"2019","journal-title":"Biomaterials"},{"key":"10.1016\/j.livres.2025.04.002_bib182","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3390\/antiox5020015","article-title":"Antioxidant cerium oxide nanoparticles in biology and medicine","volume":"5","author":"Nelson","year":"2016","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.livres.2025.04.002_bib183","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1139\/cjpp-2017-0247","article-title":"Role of zinc oxide nanoparticles in alleviating hepatic fibrosis and nephrotoxicity induced by thioacetamide in rats","volume":"96","author":"Bashandy","year":"2018","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1016\/j.livres.2025.04.002_bib184","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-49262-2","article-title":"Cerium oxide nanoparticles display antilipogenic effect in rats with non-alcoholic fatty liver disease","volume":"9","author":"Carvajal","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.livres.2025.04.002_bib185","doi-asserted-by":"crossref","first-page":"5959","DOI":"10.3390\/ijms20235959","article-title":"Cerium oxide nanoparticles protect against oxidant injury and interfere with oxidative mediated kinase signaling in human-derived hepatocytes","volume":"20","author":"Carvajal","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.livres.2025.04.002_bib186","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3390\/biom9090425","article-title":"Beyond the scavenging of reactive oxygen species (ROS): direct effect of cerium oxide nanoparticles in reducing fatty acids content in an in vitro model of hepatocellular steatosis","volume":"9","author":"Parra-Robert","year":"2019","journal-title":"Biomolecules"},{"key":"10.1016\/j.livres.2025.04.002_bib187","article-title":"The role of lipid components in lipid nanoparticles for vaccines and gene therapy","volume":"188","author":"Hald","year":"2022","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.livres.2025.04.002_bib188","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1039\/C8MD00515J","article-title":"Diversity of PEGylation methods of liposomes and their influence on RNA delivery","volume":"10","author":"Nosova","year":"2019","journal-title":"Medchemcomm"},{"key":"10.1016\/j.livres.2025.04.002_bib189","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.colsurfb.2017.07.014","article-title":"Contribution of Kupffer cells to liposome accumulation in the liver","volume":"158","author":"Samuelsson","year":"2017","journal-title":"Colloids Surf B Biointerfaces"},{"key":"10.1016\/j.livres.2025.04.002_bib190","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.nano.2019.02.019","article-title":"Liposomes produced by microfluidics and extrusion: a comparison for scale-up purposes","volume":"18","author":"Shah","year":"2019","journal-title":"Nanomedicine"},{"key":"10.1016\/j.livres.2025.04.002_bib191","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1021\/acs.biomac.2c01507","article-title":"Soy protein isolate\/genipin-based nanoparticles for the stabilization of pickering emulsion to design self-healing guar gum-based hydrogels","volume":"24","author":"Xiao","year":"2023","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.livres.2025.04.002_bib192","article-title":"Liver-on-chips for drug discovery and development","volume":"27","author":"Mehta","year":"2024","journal-title":"Mater Today Bio"},{"key":"10.1016\/j.livres.2025.04.002_bib193","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.1929","article-title":"Renal clearable magnetic nanoparticles for magnetic resonance imaging and guided therapy","volume":"16","author":"Zhang","year":"2024","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"key":"10.1016\/j.livres.2025.04.002_bib194","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.3390\/polym16172536","article-title":"Biodegradable polymeric nanoparticle-based drug delivery systems: comprehensive overview, perspectives and challenges","volume":"16","author":"Geszke-Moritz","year":"2024","journal-title":"Polymers (basel)"},{"key":"10.1016\/j.livres.2025.04.002_bib195","doi-asserted-by":"crossref","DOI":"10.1016\/j.envpol.2024.123617","article-title":"Oxidative stress and potential effects of metal nanoparticles: a review of biocompatibility and toxicity concerns","volume":"346","author":"Wang","year":"2024","journal-title":"Environ Pollut"},{"key":"10.1016\/j.livres.2025.04.002_bib196","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.3390\/pharmaceutics16121521","article-title":"Effect of lipid nanoparticle physico-chemical properties and composition on their interaction with the immune system","volume":"16","author":"Catenacci","year":"2024","journal-title":"Pharmaceutics"}],"container-title":["Liver Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2542568425000273?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2542568425000273?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T02:13:33Z","timestamp":1778897613000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2542568425000273"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":196,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S2542568425000273"],"URL":"https:\/\/doi.org\/10.1016\/j.livres.2025.04.002","relation":{},"ISSN":["2542-5684"],"issn-type":[{"value":"2542-5684","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nanoparticle-based therapeutic strategies for chronic liver diseases: Advances and insights","name":"articletitle","label":"Article Title"},{"value":"Liver Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.livres.2025.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Third Affiliated Hospital of Sun Yat-sen University. Publishing services by Elsevier B. V. on behalf of KeAi Communications Co. Ltd\u00e9","name":"copyright","label":"Copyright"}]}}